Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen E Straus

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Journal of Virology|December 15, 2004
Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigsYo Hoshino, Sarat K Dalai, Kening Wang, et al.
Virology Journal|September 28, 2011
Xenotropic murine leukemia virus-related virus is not associated with chronic fatigue syndrome in patients from different areas of the us in the 1990sMir A Ali, Janet K Dale, Christine A Kozak, et al.
Experimental Hematology|February 17, 2009
Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS)Kennichi C Dowdell, Lesley Pesnicak, Victoria Hoffmann, et al.
Nuclear Medicine and Biology|May 17, 2008
Glucose and insulin variations in patients during the time course of a FDG-PET study and implications for the "glucose-corrected" SUVMohiuddin Hadi, Stephen L Bacharach, Millie Whatley, et al.
EMBO Reports|October 30, 2004
Induction of apoptosis and activation of NF-kappaB by CD95 require different signalling thresholdsPatrick Legembre, Bryan C Barnhart, Lixin Zheng, et al.
British Journal of Haematology|May 10, 2005
Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndromeV Koneti Rao, Faith Dugan, Janet K Dale, et al.
Clinical Immunology (Orlando, Fla.)|November 1, 2005
HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia)Marla M Vacek, Alejandro A Schäffer, Joie Davis, et al.
American Journal of Ophthalmology|March 16, 2005
Bilateral uveitis in a patient with autoimmune lymphoproliferative syndromeWee-Kiak Lim, Roxana Ursea, Koneti Rao, et al.
Blood|October 25, 2003
Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturationHarutaka Katano, Mir A Ali, Andriani C Patera, et al.
Clinical Immunology (Orlando, Fla.)|July 26, 2002
Aberrant T-cell antigen receptor-mediated responses in autoimmune lymphoproliferative syndromeFrederick D Goldman, Rajeev Vibhakar, Jennifer M Puck, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Journal of Virology|December 15, 2004
Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigsYo Hoshino, Sarat K Dalai, Kening Wang, et al.
Virology Journal|September 28, 2011
Xenotropic murine leukemia virus-related virus is not associated with chronic fatigue syndrome in patients from different areas of the us in the 1990sMir A Ali, Janet K Dale, Christine A Kozak, et al.
Experimental Hematology|February 17, 2009
Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS)Kennichi C Dowdell, Lesley Pesnicak, Victoria Hoffmann, et al.
Nuclear Medicine and Biology|May 17, 2008
Glucose and insulin variations in patients during the time course of a FDG-PET study and implications for the "glucose-corrected" SUVMohiuddin Hadi, Stephen L Bacharach, Millie Whatley, et al.
EMBO Reports|October 30, 2004
Induction of apoptosis and activation of NF-kappaB by CD95 require different signalling thresholdsPatrick Legembre, Bryan C Barnhart, Lixin Zheng, et al.
British Journal of Haematology|May 10, 2005
Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndromeV Koneti Rao, Faith Dugan, Janet K Dale, et al.
Clinical Immunology (Orlando, Fla.)|November 1, 2005
HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia)Marla M Vacek, Alejandro A Schäffer, Joie Davis, et al.
American Journal of Ophthalmology|March 16, 2005
Bilateral uveitis in a patient with autoimmune lymphoproliferative syndromeWee-Kiak Lim, Roxana Ursea, Koneti Rao, et al.
Blood|October 25, 2003
Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturationHarutaka Katano, Mir A Ali, Andriani C Patera, et al.
Clinical Immunology (Orlando, Fla.)|July 26, 2002
Aberrant T-cell antigen receptor-mediated responses in autoimmune lymphoproliferative syndromeFrederick D Goldman, Rajeev Vibhakar, Jennifer M Puck, et al.
Pageof 5